Elanco Animal Health has initiated the educational program “Revise, Try, Change” aimed at supporting the poultry industry in the prevention of infectious bursal disease (IBD).
The program has started Nov. 11 with a webinar entitled “The current threat of IBD. The need for revising and optimizing IBD vaccination programs." The presentation was led by Dr. Natàlia Majó from Autonomous University of Barcelona and Dr. Guillermo Zavala from Avian Health International.
During her lecture, Dr. Majó pointed out that IBDV is slowly but continuously evolving. She presented a study showing that atypical IBDV strains isolated in Europe present different genetic and pathogenic pattern than classic IBDV. The conclusion was that epidemiological follow-up and revision of IBD vaccination programs are crucial to ensure effective protection against IBD.
Dr. Zavala highlighted the complex IBDV interaction with other pathogens, its high resistance and high mutation rate that may give rise to viruses with increased virulence. He concluded that these features make IBD an endemic, persisting and evolving worldwide problem, which requires established IBD vaccination programs to be reviewed, evaluated and challenged periodically to ensure a proper IBD control.
Elanco provides the vaccines AviPro®Precise and AviPro®IBD Xtreme as well as an experienced technical support team to support producers and veterinarians in controlling IBD. For more information, please visit revise-try-change.com.
Showing posts with label IBD. Show all posts
Showing posts with label IBD. Show all posts
Thursday, December 10, 2015
Monday, March 24, 2014
New case of IBD virus confirmed in Washington
A new case of infectious bursal disease (IBD) virus, which is not known to infect humans or other animals, has now been confirmed in one flock of birds in the state of Washington, according to a report from Washington State University (WSU).
The viral poultry disease can result in high death losses in flocks, affecting young birds significantly. The disease can also suppress the birds' immune system, making them more vulnerable to secondary disease resulting in birds that do not die quickly.
Other forms of the virus are present throughout the U.S., but this new version has been reported only prior in California, and now, the state of Washington. The disease is not a regulated, reportable one, and is usually managed by poultry veterinarians and flock owners through biosecurity and disinfection.
Wild birds, such as healthy ducks, guinea fowl, quail and pheasants, have been found to be naturally infected with IBD virus, but they do not appear to be significant in the spread of disease to domestic poultry, according to WSU.
Diagnosis is based on clinical signs including death losses, depression and ruffling of feathers, poor appetite, huddling, an unsteady gate, reluctance to rise and diarrhea. As a result, the disease can be confused with other poultry diseases.
Experts advise that definitive diagnosis is made through post-mortem examination and virus testing. WSU says the Washington State University-Washington Animal Disease Diagnostic Laboratories in Pullman, Wash., and the WSU Avian Health and Food Safety Laboratory in Puyallup, Wash., can provide assistance and testing of recently deceased birds.
The viral poultry disease can result in high death losses in flocks, affecting young birds significantly. The disease can also suppress the birds' immune system, making them more vulnerable to secondary disease resulting in birds that do not die quickly.
Other forms of the virus are present throughout the U.S., but this new version has been reported only prior in California, and now, the state of Washington. The disease is not a regulated, reportable one, and is usually managed by poultry veterinarians and flock owners through biosecurity and disinfection.
Wild birds, such as healthy ducks, guinea fowl, quail and pheasants, have been found to be naturally infected with IBD virus, but they do not appear to be significant in the spread of disease to domestic poultry, according to WSU.
Diagnosis is based on clinical signs including death losses, depression and ruffling of feathers, poor appetite, huddling, an unsteady gate, reluctance to rise and diarrhea. As a result, the disease can be confused with other poultry diseases.
Experts advise that definitive diagnosis is made through post-mortem examination and virus testing. WSU says the Washington State University-Washington Animal Disease Diagnostic Laboratories in Pullman, Wash., and the WSU Avian Health and Food Safety Laboratory in Puyallup, Wash., can provide assistance and testing of recently deceased birds.
Wednesday, February 17, 2010
Avian scientists discuss Gumboro disease at Merial summit
More than 150 veterinarians and poultry production specialists from 21 countries gathered in Atlanta recently to learn about effective control of infectious bursal disease, also known as IBD or Gumboro disease, at a summit sponsored by animal health company Merial.
IBD is one of the most widely recognized diseases affecting chickens globally and is a major cause of immunosuppression and mortality, according to Merial.
John R. Glisson, a doctor of veterinary medicine at the University of Georgia, kicked off the symposium, speaking about the history and control of avian diseases, from the days of Louis Pasteur to today’s use of vector vaccine technology.
Academic veterinarians from the United States and Venezuela discussed diagnostic methods for IBD and the use of vector vaccine technology to control it. Industry veterinarians from Venezuela and the United States reported positive economic and production results from using the Merial Vaxxitek HVT+IBD vector vaccine against Marek’s disease and IBD in commercial production. The vaccine has been used in 5 billion chicken worldwide since its launch in 2006, according to the company.
Vertically integrated producers from Asia also attended the conference.
IBD is one of the most widely recognized diseases affecting chickens globally and is a major cause of immunosuppression and mortality, according to Merial.
John R. Glisson, a doctor of veterinary medicine at the University of Georgia, kicked off the symposium, speaking about the history and control of avian diseases, from the days of Louis Pasteur to today’s use of vector vaccine technology.
Academic veterinarians from the United States and Venezuela discussed diagnostic methods for IBD and the use of vector vaccine technology to control it. Industry veterinarians from Venezuela and the United States reported positive economic and production results from using the Merial Vaxxitek HVT+IBD vector vaccine against Marek’s disease and IBD in commercial production. The vaccine has been used in 5 billion chicken worldwide since its launch in 2006, according to the company.
Vertically integrated producers from Asia also attended the conference.
Subscribe to:
Posts (Atom)
